NCT05308875View on ClinicalTrials.gov

Efficacy and Safety Evaluation of PD1-BCMA-CART

NAUnknownINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

October 1, 2025

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

PD1-BCMA-CART

Single infusion of PD1-BCMA-CART administered intravenously (i.v.)

Trial Locations (1)

450052

First Affliated Hospital of Zhengzhou University, Zhengzhou

Sponsors
All Listed Sponsors
collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

lead

Bioray Laboratories

INDUSTRY

NCT05308875 - Efficacy and Safety Evaluation of PD1-BCMA-CART | Biotech Hunter | Biotech Hunter